Amphotericin B nephrotoxicity

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue SUPL. S1, 2002, Pages 37-41

  Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; BIOCHEMICAL MARKER; CREATININE; FUROSEMIDE; GLUCOSE; INTRALIPID; MANNITOL;

ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; EARLY DIAGNOSIS; FUNGAL MENINGITIS; HEMODIALYSIS; HOSPITAL COST; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; KIDNEY DISEASE; KIDNEY TUBULE ACIDOSIS; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NEPHROTOXICITY; POLYURIA; RANDOMIZED CONTROLLED TRIAL; RIGOR; RISK FACTOR; UREMIA;

EID: 0036177169     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/49.suppl_1.37     Document Type: Article

References (17)

1. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
2. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
3. Renal effects of amphotericin B lipid complex
4. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
5. On the nephrotoxicity of amphotericin B in man
6. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients
7. A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with haematological malignancies
8. Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: Results of a prospective, randomized, controlled study in critically ill patients
9. Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: Randomised study
10. Comparison of the toxicity of amphotericin B in 5% dextrose with that of amphotericin B in fat emulsion in a randomized trial with cancer patients
11. Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys
12. Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B
13. Risk factors of ventricular fibrillation during rapid amphotericin B infusion
14. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS
15. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
16. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections
17. A randomized double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia